Analyst Ratings for Legand Biotech Corp. (LEGN)

LEGN Rating Summary

LEGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LEGN
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $63.14 (+52.1%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/15/2022 Barclays Gena Wang New Coverage Overweight
(N/A)
53.00
(N/A)
31.02
(41.52)
33.85% Details
1/31/2022 Morgan Stanley
» Updated 3/7/2022
Matthew Harrison Upgrade Overweight
(Equalweight)
55.00
(51.00)
35.78
(41.52)
16.04% Details
Like LEGN Ratings? Also take a look at FATE, CRBU, MTEM, BGNE

LEGN Ratings News